Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014802 · ClinicalTrials.gov registry record
Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
A clinical trial of Atrial Fibrillation and Atrial Flutter, sponsored by Tulane University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 3
- Study locations
NCT05014802 is a study of Atrial Fibrillation and Atrial Flutter that is actively recruiting participants, run by Tulane University. The registered enrollment target is 50 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT05014802, a study of Atrial Fibrillation and Atrial Flutter, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize that patients with a higher baseline Utah fibrosis staging will experience a higher incidence of POAF. The study also aims to evaluate and compare the in-hospital mortality, length-of-stay (LOS), complication rates (strokes, pneumonia, respiratory failure etc.) of the different Utah fibrosis stage cohorts. Perform cost analysis and compare between patients with POAF and patients without POAF. The investigators hypothesize that patients experiencing POAF will have a higher mortality rate, longer LOS, greater complications, and therefore, additional hospital costs.
Conditions Studied
Study Locations (3)
Louisiana
- Lakeview Hospital - Covington
- East Jefferson General Hospital - New Orleans
Missouri
- Washington University Barnes-Jewish Hospital - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-11-21 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05014802
The ClinicalTrials.gov registry entry for NCT05014802 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT05014802 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Louisiana, Missouri.
Frequently Asked Questions
What is clinical trial NCT05014802 about?
NCT05014802 is a clinical study titled "Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery". The study aims to evaluate and compare the incidence of atrial arrhythmias (including Post-Operative Atrial Fibrillation (POAF), atrial flutter, and atrial tachycardia) stratified by baseline Utah fibrosis stages and overall fibrosis (%) of the left atrial wall area. The investigators hypothesize th...
What is the current status of trial NCT05014802?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2021-11-21. Estimated completion is 2026-08.
What conditions does trial NCT05014802 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Atrial Flutter, Atrial Arrhythmia, Atrial Tachycardia.
Who is sponsoring clinical trial NCT05014802?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05014802 being conducted?
This trial has 3 study locations across Louisiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.